文献速递银屑病与炎症性皮肤病

抗生素使用与银屑病患者生物制剂持续性的关联

Antibiotic Use and the Persistence of Biologic Therapies in Patients With Psoriasis.
PubMed 文献 · JAMA Dermatol · 2026-01-01

结果显示,抗生素暴露与生物制剂停用风险升高相关(加权HR 1.12,95%CI 1.08-1.16),多次配药者风险更高(加权HR 1.29,95%CI 1.24-1.35),提示剂量反应关系。

要点

  • 抗生素暴露与银屑病生物制剂停用风险升高相关,多次暴露风险更高。
  • 基线25.9%和随访期间60.6%的患者有抗生素暴露。
  • 最常见抗生素类别为β-内酰胺类、大环内酯类和氟喹诺酮类。

核心结论

  • 抗生素暴露与银屑病患者生物制剂停用风险显著升高相关,支持抗生素可能通过肠道菌群失调降低生物制剂持续性的假设。

主要发现

  • 抗生素暴露与生物制剂停用风险升高相关(加权HR 1.12,95%CI 1.08-1.16)。
  • 多次抗生素配药者风险更高(加权HR 1.29,95%CI 1.24-1.35),提示剂量反应关系。
  • 最常见处方抗生素类别为β-内酰胺类、大环内酯类和氟喹诺酮类。

临床怎么用

  • 临床对银屑病生物制剂治疗患者应审慎评估抗生素使用必要性,尤其避免不必要的多次暴露。

局限性

  • 存在未测量混杂因素,限制因果解释。
  • 需进一步研究验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The long-term effectiveness of biologic therapies in psoriasis may decline over time. Gut microbiota alterations induced by antibiotics have been proposed as a potential mechanism impairing biologic persistence. OBJECTIVE: To evaluate the association between antibiotic exposure and the persistence of biologic therapies in patients with psoriasis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from the French National Health Insurance database between June 2011 and December 2022. Adults initiating a biologic therapy for psoriasis were included, excluding those with preexisting inflammatory bowel disease at baseline. Data were analyzed from January to September 2024. EXPOSURES: At baseline, antibiotics exposure was classified as none, 1, or 2 or more dispensations in the 6 months preceding the index date. During follow-up, time-dependent antibiotics exposure was defined as none, 1, or 2 or more antibiotics dispensations in the 6 months prior to each time of follow-up. MAIN OUTCOMES AND MEASURES: The primary outcome was discontinuation or switch of the initial biologic therapy. Exposure to antibiotics was assessed within 6 months prior to biologic initiation and during follow-up. A weighted Cox marginal structural model was used to estimate adjusted hazard ratios. RESULTS: Of 36 129 included patients, 11 228 (42.0%) were female, 20 192 (55.9%) were male, and the mean (SD) age was 48.4 (15.1) years. A total of 9366 (25.9%) were exposed to antibiotics at baseline and 21 900 (60.6%) during follow-up. The most commonly prescribed antibiotic classes were β-lactams, macrolides, and fluoroquinolones. Antibiotic exposure was associated with a higher risk of biologic discontinuation (weighted hazard ratio, 1.12; 95% CI, 1.08-1.16), with a stronger effect observed for multiple dispensations (weighted hazard ratio, 1.29; 95% CI, 1.24-1.35), suggesting a dose-response relationship. CONCLUSIONS AND RELEVANCE: In this cohort study, antibiotic exposure was significantly associated with an increased risk of discontinuation of biologic therapies in psoriasis. These findings support the hypothesis that antibiotics, potentially through gut dysbiosis, may reduce biologic persistence. However, unmeasured confounders limit causal interpretation. Further studies are necessary to validate these findings.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Ouakrat R, Penso L, Jullien D, et al. Antibiotic Use and the Persistence of Biologic Therapies in Patients With Psoriasis. JAMA Dermatol. 2026. PMID: 41222929. doi:10.1001/jamadermatol.2025.4427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。